Exelixis
EXEL
#1727
Rank
โ‚ฌ10.19 B
Marketcap
38,02ย โ‚ฌ
Share price
-0.36%
Change (1 day)
11.97%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no stock splits for this company